Personalized heparin dosing may speed up treatment for clots and heart issues
NCT ID NCT07250763
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tests whether using a patient's gender, weight, and kidney function to calculate the first dose of the blood thinner heparin helps reach the target level faster than using a standard dose based only on weight. About 145 adults with conditions like deep vein thrombosis, pulmonary embolism, atrial fibrillation, or mechanical heart valves will take part. The goal is to improve treatment speed and reduce the risk of under- or over-dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inova Alexandria Hospital
Alexandria, Virginia, 22304, United States
Conditions
Explore the condition pages connected to this study.